BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31831842)

  • 1. Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP).
    Nielsen NV; Roedel E; Manna D; Etscheid M; Morth JP; Kanse SM
    Sci Rep; 2019 Dec; 9(1):18990. PubMed ID: 31831842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
    Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
    Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
    Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
    Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor seven activating protease (FSAP): does it activate factor VII?
    Stavenuiter F; Dienava-Verdoold I; Boon-Spijker MG; Brinkman HJ; Meijer AB; Mertens K
    J Thromb Haemost; 2012 May; 10(5):859-66. PubMed ID: 22235940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
    Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
    Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
    Muhl L; Hersemeyer K; Preissner KT; Weimer T; Kanse SM
    FEBS Lett; 2009 Jun; 583(12):1994-8. PubMed ID: 19446554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model.
    Kara E; Nielsen NV; Eggertsdottir B; Thiede B; Kanse SM; Løset GÅ
    Chembiochem; 2020 Jul; 21(13):1875-1884. PubMed ID: 32180321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
    Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
    FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
    Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
    J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSAP Protects against Histone-Mediated Increase in Endothelial Permeability In Vitro.
    Cui XY; Stavik B; Thiede B; Sandset PM; Kanse SM
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).
    Roemisch J; Feussner A; Nerlich C; Stoehr HA; Weimer T
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):433-41. PubMed ID: 12138371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
    Artunc F; Bohnert BN; Schneider JC; Staudner T; Sure F; Ilyaskin AV; Wörn M; Essigke D; Janessa A; Nielsen NV; Birkenfeld AL; Etscheid M; Haerteis S; Korbmacher C; Kanse SM
    Pflugers Arch; 2022 Feb; 474(2):217-229. PubMed ID: 34870751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
    Kim JY; Manna D; Etscheid M; Leergaard TB; Kanse SM
    FASEB J; 2022 Oct; 36(10):e22564. PubMed ID: 36165219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).
    Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT
    Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population.
    Parahuleva MS; Schieffer B; Klassen M; Worsch M; Parviz B; Hölschermann H
    Med Sci Monit; 2018 Jun; 24():4271-4278. PubMed ID: 29927903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
    Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
    Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct chromogenic substrate immuno-capture activity assay for testing of factor VII-activating protease.
    Stephan S; Schwarz H; Haude-Barten A; Sidelmann JJ; Fischer B; Althaus H; Hahn M; Kappel A; Ehm M; Vitzthum F
    Clin Chem Lab Med; 2011 Jul; 49(7):1199-204. PubMed ID: 21663569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells.
    Byskov K; Boettger T; Ruehle PF; Nielsen NV; Etscheid M; Kanse SM
    Atherosclerosis; 2017 Oct; 265():133-139. PubMed ID: 28881271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activated receptors (PAR)-1 and -2 mediate cellular effects of factor VII activating protease (FSAP).
    Byskov K; Le Gall SM; Thiede B; Camerer E; Kanse SM
    FASEB J; 2020 Jan; 34(1):1079-1090. PubMed ID: 31914657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease.
    Stephan F; Dienava-Verdoold I; Bulder I; Wouters D; Mast AE; Te Velthuis H; Aarden LA; Zeerleder S
    J Thromb Haemost; 2012 Jun; 10(6):1165-71. PubMed ID: 22449009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.